Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 24, 2017
Pharmacy Choice - Pharmaceutical News - Prescribing generic medicines may commoditise entire pharma industry: Experts [T-break Tech (Middle East)] - July 24, 2017

Pharmacy News Article

 4/19/17 - Prescribing generic medicines may commoditise entire pharma industry: Experts [T-break Tech (Middle East)]

To break the nexus between pharmaceutical companies and doctors pushing expensive branded medicines, Prime Minister Narendra Modi yesterday, announced a major step. He said the government will soon put in place a legal framework to ensure doctors prescribe low-cost generic medicines to patients.

Kewal Handa, Former MD, Pfizer and Chaturya Aggarwal, Pharma Analyst at IDBI Capital discuss the impact of the above decision on the healthcare and pharma industry.

Handa says, for this to be a success the first thing government has to see is that the companies that will manufacture generic-generic drugs are aligned to global manufacturing practices. The quality will be a big issue and doctors may not have confidence in prescribing a generic-generic drug and may not take responsibility for the patients care, he says in an interview to CNBC-TV18.

Currently, India has three kinds of categories patented products, branded-generic and generic-generic drugs/medicines.

The biggest challenge is we will be moving from the doctors controlled to hands of retailers (e-commerce), which will be a big risk, says Handa.

According to him, the risk of this shift in control to retailers would mean that they would push only those products that give higher margins and not quality products necessarily and this could over longer period of time reduce prices.

The drugs will be sold as commodities, says Handa, adding that this will commoditise the entire pharma industry, which would be unfair.

The cost of manufacturing a branded-generic and generic-generic drug may be the same for manufacturer unless it is manufactured in an USFDA approved plant compared to maybe a plant that has been locally approved, says Handa. The government should instead look at universal health policy, he said.

Chaturya Aggarwal says shifting the business from branded-generic to generic-generic will take a long time to happen.



(c) 2017 TBREAK MEDIA. ALL RIGHTS RESERVED. Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Jul 24: What's New? New Treatments for Type 2 Diabetes
Jul 26: Management of Schizophrenia & Acute Agitation
Jul 27: On the Move: A Comprehensive Review of Osteoarthritis, Gout & Rheumatoid Arthritis
Jul 31: Obesity Management: Overview of Pharmacotherapy
Aug 01: Treatment of Depression and Anxiety in Older Adults
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415